Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance.

Binder U, Aigner M, Risslegger B, Hörtnagl C, Lass-Flörl C, Lackner M.

J Fungi (Basel). 2019 Sep 4;5(3). pii: E83. doi: 10.3390/jof5030083.

2.

Hypoxia Decreases Diagnostic Biomarkers for Aspergillosis In Vitro.

Maurer E, Aigner M, Lass-Flörl C, Binder U.

J Fungi (Basel). 2019 Jul 11;5(3). pii: E61. doi: 10.3390/jof5030061.

3.

Antifungal susceptibility profiles of rare ascomycetous yeasts.

Pérez-Hansen A, Lass-Flörl C, Lackner M; Rare Yeast Study Group .

J Antimicrob Chemother. 2019 Sep 1;74(9):2649-2656. doi: 10.1093/jac/dkz231.

PMID:
31203366
4.

Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity.

Haug T, Aigner M, Peuser MM, Strobl CD, Hildner K, Mougiakakos D, Bruns H, Mackensen A, Völkl S.

Front Immunol. 2019 Apr 26;10:883. doi: 10.3389/fimmu.2019.00883. eCollection 2019.

5.

[Ketamine in the therapy of chronic pain and depression].

Jaksch W, Likar R, Aigner M.

Wien Med Wochenschr. 2019 Apr 12. doi: 10.1007/s10354-019-0695-x. [Epub ahead of print] Review. German.

PMID:
30980201
6.

Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients.

Aigner M, Wanner M, Kreidl P, Lass-Flörl C, Lackner M.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00138-19. doi: 10.1128/AAC.00138-19. Print 2019 Jun.

PMID:
30936100
7.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

8.

Label-Free Imaging of Single Proteins Secreted from Living Cells via iSCAT Microscopy.

Gemeinhardt A, McDonald MP, König K, Aigner M, Mackensen A, Sandoghdar V.

J Vis Exp. 2018 Nov 20;(141). doi: 10.3791/58486.

PMID:
30531724
9.

SSZ-70 borosilicate delamination without sonication: effect of framework topology on olefin epoxidation catalysis.

Okrut A, Aigner M, Schöttle C, Grosso-Giordano NA, Hwang SJ, Ouyang X, Zones S, Katz A.

Dalton Trans. 2018 Oct 30;47(42):15082-15090. doi: 10.1039/c8dt03044h.

PMID:
30303227
10.

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.

Braciak TA, Roskopf CC, Wildenhain S, Fenn NC, Schiller CB, Schubert IA, Jacob U, Honegger A, Krupka C, Subklewe M, Spiekermann K, Hopfner KP, Fey GH, Aigner M, Krause S, Mackensen A, Oduncu FS.

Oncoimmunology. 2018 Jul 30;7(9):e1472195. doi: 10.1080/2162402X.2018.1472195. eCollection 2018.

11.

Personality functioning in anxiety disorders.

Doering S, Blüml V, Parth K, Feichtinger K, Gruber M, Aigner M, Rössler-Schülein H, Freidl M, Wininger A.

BMC Psychiatry. 2018 Sep 14;18(1):294. doi: 10.1186/s12888-018-1870-0.

12.

Impact of collection programs for the generation of monocyte apheresis products on product quality and composition as starting material for the generation of cellular therapeutics.

Pfeiffer H, Völkl S, Gary R, Mackensen A, Achenbach S, Strasser E, Aigner M.

Transfusion. 2018 Sep;58(9):2175-2183. doi: 10.1111/trf.14817.

PMID:
30204947
13.

A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria.

Lass-Flörl C, Mayr A, Aigner M, Lackner M, Orth-Höller D.

Infection. 2018 Oct;46(5):701-704. doi: 10.1007/s15010-018-1170-0. Epub 2018 Jul 3.

14.

Influence of CRHR1 Polymorphisms and Childhood Abuse on Suicide Attempts in Affective Disorders: A GxE Approach.

Ludwig B, Kienesberger K, Carlberg L, Swoboda P, Bernegger A, Koller R, Wang Q, Inaner M, Zotter M, Kapusta ND, Haslacher H, Aigner M, Kasper S, Schosser A.

Front Psychiatry. 2018 Apr 26;9:165. doi: 10.3389/fpsyt.2018.00165. eCollection 2018.

15.

Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts.

Gary R, Aigner M, Moi S, Schaffer S, Gottmann A, Maas S, Zimmermann R, Zingsem J, Strobel J, Mackensen A, Mautner J, Moosmann A, Gerbitz A.

J Transl Med. 2018 May 9;16(1):124. doi: 10.1186/s12967-018-1498-3.

16.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

17.

A Dominant Negative Antisense Approach Targeting β-Catenin.

Vonbrüll M, Riegel E, Halter C, Aigner M, Bock H, Werner B, Lindhorst T, Czerny T.

Mol Biotechnol. 2018 May;60(5):339-349. doi: 10.1007/s12033-018-0058-7.

18.

The Impact of COMT and Childhood Maltreatment on Suicidal Behaviour in Affective Disorders.

Bernegger A, Kienesberger K, Carlberg L, Swoboda P, Ludwig B, Koller R, Inaner M, Zotter M, Kapusta N, Aigner M, Haslacher H, Kasper S, Schosser A.

Sci Rep. 2018 Jan 12;8(1):692. doi: 10.1038/s41598-017-19040-z.

19.

The function of tcf3 in medaka embryos: efficient knockdown with pePNAs.

Doenz G, Dorn S, Aghaallaei N, Bajoghli B, Riegel E, Aigner M, Bock H, Werner B, Lindhorst T, Czerny T.

BMC Biotechnol. 2018 Jan 9;18(1):1. doi: 10.1186/s12896-017-0411-0.

20.

Visualizing Single-Cell Secretion Dynamics with Single-Protein Sensitivity.

McDonald MP, Gemeinhardt A, König K, Piliarik M, Schaffer S, Völkl S, Aigner M, Mackensen A, Sandoghdar V.

Nano Lett. 2018 Jan 10;18(1):513-519. doi: 10.1021/acs.nanolett.7b04494. Epub 2017 Dec 19.

PMID:
29227108

Supplemental Content

Loading ...
Support Center